tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Neurotech International Enhances US Presence with New Chief Medical Advisor
Company AnnouncementsNeurotech International Enhances US Presence with New Chief Medical Advisor
21d ago
NTI
Neurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
PremiumCompany Announcements
Neurotech’s NTI164 to be Highlighted at Rett Syndrome Scientific Meeting
1M ago
NTI
Neurotech International’s NTI164 Shows Promising PK Study Results
PremiumCompany Announcements
Neurotech International’s NTI164 Shows Promising PK Study Results
1M ago
NTI
Neurotech International Advances in Pediatric Neurological Treatments
PremiumCompany Announcements
Neurotech International Advances in Pediatric Neurological Treatments
2M ago
NTI
Neurotech International Updates Trading Policy to Enhance Compliance
PremiumCompany Announcements
Neurotech International Updates Trading Policy to Enhance Compliance
3M ago
NTI
Neurotech International Issues New Shares, Ensures Regulatory Compliance
PremiumCompany AnnouncementsNeurotech International Issues New Shares, Ensures Regulatory Compliance
3M ago
NTI
Neurotech International Expands Share Issuance to Boost Market Position
Premium
Company Announcements
Neurotech International Expands Share Issuance to Boost Market Position
3M ago
NTI
Neurotech International Announces Director Resignation
Premium
Company Announcements
Neurotech International Announces Director Resignation
3M ago
NTI
Neurotech International Announces Executive Director Resignation
PremiumCompany Announcements
Neurotech International Announces Executive Director Resignation
3M ago
NTI
Neurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
PremiumCompany Announcements
Neurotech’s NTI164 Receives EU Orphan Drug Designation for Rett Syndrome
3M ago
NTI
Neurotech Retracts Market Opportunity Statement
PremiumCompany Announcements
Neurotech Retracts Market Opportunity Statement
3M ago
NTI
Neurotech Publishes Positive Phase I/II ASD Trial Results
PremiumCompany Announcements
Neurotech Publishes Positive Phase I/II ASD Trial Results
3M ago
NTI
Neurotech International Unveils Strategic Plans at NWR Virtual Healthcare Conference
PremiumCompany AnnouncementsNeurotech International Unveils Strategic Plans at NWR Virtual Healthcare Conference
4M ago
NTI
Neurotech International to Present at NWR Virtual Healthcare Conference
Premium
Company Announcements
Neurotech International to Present at NWR Virtual Healthcare Conference
4M ago
NTI
Neurotech International Reports Significant Loss Amid Increased R&D Investment
Premium
Company Announcements
Neurotech International Reports Significant Loss Amid Increased R&D Investment
4M ago
NTI
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
PremiumCompany Announcements
Neurotech Secures EMA Positive Opinion for NTI164 in Rett Syndrome
4M ago
NTI
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
PremiumCompany Announcements
Director of Neurotech International Ltd. Increases Stake with Options Acquisition
4M ago
NTI
Neurotech International Issues New Unquoted Equity Options
PremiumCompany Announcements
Neurotech International Issues New Unquoted Equity Options
4M ago
NTI
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
PremiumCompany Announcements
Neurotech International Enhances Cannabinoid Drug Development Through New Partnership
5M ago
NTI
Neurotech International Appoints New CEO with Incentive Plan
PremiumCompany AnnouncementsNeurotech International Appoints New CEO with Incentive Plan
5M ago
NTI
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
Premium
Company Announcements
Neurotech Bolsters Cash Position with $2.44 Million R&D Tax Incentive Refund
5M ago
NTI
Neurotech Advances NTI164 Clinical Trials Amid Regulatory Developments
Premium
Company Announcements
Neurotech Advances NTI164 Clinical Trials Amid Regulatory Developments
5M ago
NTI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >